Who is sponsoring NCT02345785?

NCT02345785 is sponsored by Yonsei University.

What drugs are being tested in NCT02345785?

Interventions in NCT02345785: urologic surgery and caudal block.

What condition does NCT02345785 study?

NCT02345785 studies Pediatric Urologic Surgeries.

Is NCT02345785 still recruiting?

NCT02345785 is currently completed. Last updated 26 February 2019.

Last reviewed 2019-02-26 · How we verify

NCT02345785

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Change of Penile Corpus Cavernosum After Caudal Block Using Ultrasonography in Children

Completed Last updated 26 February 2019

What this trial tests

trial testing urologic surgery and caudal block in Pediatric Urologic Surgeries in 6 participants. Completed in 22 January 2016.

Timeline

2 October 2015

Primary endpoint
22 January 2016

22 January 2016

Quick facts

Lead sponsor	Yonsei University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	6
Start date	2 October 2015
Primary completion	22 January 2016
Estimated completion	22 January 2016
Sites	1 location across South Korea

Drugs / interventions tested

urologic surgery and caudal block

Conditions studied

Pediatric Urologic Surgeries — all drugs for Pediatric Urologic Surgeries →

Sponsor

Yonsei University

Who can join

Adults 2 to 7, any sex, with Pediatric Urologic Surgeries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the change of penile corpus cavernosum after caudal block using ultrasonography in pediatric patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Yonsei University trials

Trials by the same sponsor.

NCT07547592 — Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma · Phase 2 · not yet recruiting
NCT07524101 — Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD · NA · not yet recruiting
NCT07506629 — Adductor Canal Block Methods in Bilateral Total Knee Arthroplasty · NA · not yet recruiting
NCT07515716 — Effects of High Flow Humidified Oxygen on Umbilical Artery Acid-base Balance in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07507188 — Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02345785 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yonsei University
Last refreshed: 26 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02345785.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing